blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2702064

EP2702064 - KINASE INHIBITORS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  17.02.2017
Database last updated on 06.07.2024
FormerExamination is in progress
Status updated on  15.11.2016
Most recent event   Tooltip17.02.2017Application deemed to be withdrawnpublished on 22.03.2017  [2017/12]
Applicant(s)For all designated states
Icahn School of Medicine at Mount Sinai
One Gustave L. Levy Place
New York, NY 10029 / US
[2014/10]
Inventor(s)01 / REDDY, M.V. Ramana
106 Doral Drive
Blue Bell, PA 19422 / US
02 / REDDY, E., Premkumar
547 Atterbury Road
Vilanova, PA 19085 / US
 [2014/10]
Representative(s)Grünecker Patent- und Rechtsanwälte PartG mbB
Leopoldstraße 4
80802 München / DE
[N/P]
Former [2014/10]Grünecker, Kinkeldey, Stockmair & Schwanhäusser
Leopoldstrasse 4
80802 München / DE
Application number, filing date12776807.530.04.2012
WO2012US35880
Priority number, dateUS201161480687P29.04.2011         Original published format: US 201161480687 P
[2014/10]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012149567
Date:01.11.2012
Language:EN
[2012/44]
Type: A1 Application with search report 
No.:EP2702064
Date:05.03.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 01.11.2012 takes the place of the publication of the European patent application.
[2014/10]
Search report(s)International search report - published on:US01.11.2012
(Supplementary) European search report - dispatched on:EP04.09.2014
ClassificationIPC:C07D513/04
[2014/10]
CPC:
C07D513/04 (EP,CN,KR,US); A61K31/542 (KR); A61P15/00 (EP);
A61P17/02 (EP); A61P19/00 (EP); A61P19/08 (EP);
A61P21/02 (EP); A61P25/00 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P9/00 (EP); C07D239/38 (CN);
C07D239/47 (EP,CN,US); C07D239/48 (US); C07D239/56 (CN,US);
C07D239/58 (CN,US); C07D401/12 (CN,US); C07D403/12 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/10]
TitleGerman:KINASE-INHIBITOREN[2014/10]
English:KINASE INHIBITORS[2014/10]
French:INHIBITEURS DE KINASES[2014/10]
Entry into regional phase25.11.2013National basic fee paid 
25.11.2013Search fee paid 
25.11.2013Designation fee(s) paid 
25.11.2013Examination fee paid 
Examination procedure25.11.2013Examination requested  [2014/10]
02.04.2015Amendment by applicant (claims and/or description)
07.06.2016Despatch of a communication from the examining division (Time limit: M04)
18.10.2016Application deemed to be withdrawn, date of legal effect  [2017/12]
16.11.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2017/12]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  07.06.2016
Fees paidRenewal fee
28.04.2014Renewal fee patent year 03
27.04.2015Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
30.04.201605   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO9950257  (WARNER LAMBERT CO [US], et al) [A] 1-30* page 125; claim 1 *;
 [A]  - A. S. Sokolova ET AL, "SYNTHESIS AND BIOLOGICAL PROPERTIES OF PYRIMIDO[4.5-b][1.4]- THIAZINE DERIVATIVES", Pharmaceutical Chemistry Journal, (19770101), pages 1205 - 1210, URL: http://rd.springer.com/content/pdf/10.1007/BF00777737.pdf, (20140820), XP055135605 [A] 1-30 * page 1206; compounds IIIa-IIIe * * page 1207; table I *

DOI:   http://dx.doi.org/10.1007/BF00777737
 [A]  - N I Traven ET AL, "SYNTHESIS AND ANTITUMOR ACTIVITY OF 6-OXO-7-AMINO-5H-PYRIDO [2,3-b]- AND 5H-PYRIMIDO [4,5-b ] [ 1,4 ] THIAZINES", Pharmaceutical Chemistry Journal, (19840101), pages 674 - 678, URL: http://rd.springer.com/content/pdf/10.1007/BF00773011.pdf, (20140820), XP055135622 [A] 1-30 * page 674; compounds I-II, IV-V, VII-VIII, XI-XIII, XV-XVI * * page 678; table 2 *

DOI:   http://dx.doi.org/10.1007/BF00773011
 [A]  - T S Safonova ET AL, "SEARCH FOR NEW DRUGS SYNTHESIS AND ANTITUMOR ACTIVITY OF PYRIMIDO[4,5-b] [1,4]THIAZIN-6-ONE-7-ACETIC ACID DERIVATIVES 1", Pharmaceutical Chemistry Journal, (19990101), pages 6 - 8, URL: http://rd.springer.com/content/pdf/10.1007/BF02508406.pdf, (20140820), XP055135624 [A] 1-30 * page 5 - page 6; compound IX *
International search[A]US4755509  (TEULON JEAN-MARIE [FR]);
 [A]US5252571  (AOTSUKA TOMOJI [JP], et al);
 [A]US5556841  (KAWASHIMA YOICHI [JP], et al);
 [X]US2003187256  (BERRYMAN KENT ALAN [US], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.